Since the beginning of May, officials from the Ministry of Health of the Iranian regime have been sounding alarms about the potential spread of dengue fever.
They predict that the disease will likely see a surge in cases during September and October. This warning has stoked fears among the Iranian populace, who are still reeling from the devastating impact of the COVID-19 pandemic.
The regime’s previous negligence in timely vaccine procurement during the COVID-19 crisis resulted in the loss of at least 500,000 lives, and its aftermath continues to haunt the nation.
Unlike many other countries, Iran faces a significant challenge in accessing dengue vaccines. The Ministry of Health has decided to administer the dengue vaccine only to those who have previously been infected or have underlying health conditions. This limited access exacerbates the public’s anxiety.
A Global Perspective on Dengue Fever
According to the World Health Organization (WHO), dengue fever has seen widespread incidence globally in 2024. In the first six months alone, more than 10 million cases were reported worldwide, with over 5,000 fatalities across 80 countries. Several factors contribute to this increase, including climate change, urbanization, and the proliferation of the invasive Aedes mosquito.
Regions ranging from the Americas to Southeast Asia and the Western Pacific are grappling with dengue outbreaks. Countries like Bangladesh, Malaysia, Thailand, and Vietnam have reported the highest number of cases.
Dengue Fever in Iran
Dengue fever, predominantly a tropical disease, made its initial appearance in Iran along the shores of the Persian Gulf. Health officials attributed its introduction to infected individuals traveling from countries such as the United Arab Emirates. Subsequently, cases emerged in Iran’s northern provinces, and the disease has now spread to Khuzestan, Isfahan, Hormozgan, Sistan and Baluchistan, Bushehr, and Golestan.
Last year, the Ministry of Health recorded 75 cases of dengue fever. This year, the number has escalated to 149 confirmed cases. However, this figure only includes officially confirmed instances, suggesting the actual number may be higher.
Government Response and Public Concern
Health Minister Bahram Eynollahi has acknowledged the possibility that dengue fever could evolve into an epidemic. Other officials within the Ministry of Health have also indicated that the disease’s spread in the coming months is likely. This has led to growing concern, with some dubbing dengue fever the ‘second coronavirus.’
A report in the state-run daily Donya-e Eghtesad, quoting virologist Talat Mokhtari, highlighted the danger of dengue fever potentially infecting more people than anticipated. The public’s frustration is further fueled by the insufficient availability of vaccines, a result of what many perceive as the regime’s inhumane policies.
Shahnam Arshi, head of the infectious disease management center at the Ministry of Health, confirmed that the dengue vaccine is administered “in a limited way and in special cases.” He also claimed that the vaccine is not widely available in other countries, a statement that offers little comfort to the anxious public.
The Nature and Spread of Dengue Fever
Dengue fever, often referred to as ‘bone-breaking fever,’ is transmitted through the bite of the invasive Aedes mosquito, also known as the Asian tiger mosquito. These mosquitoes thrive in hot climates and densely populated areas lacking clean water, proper sanitation, and effective waste management.
As Iran braces for the potential spread of dengue fever, the need for comprehensive public health measures and accessible vaccines becomes increasingly urgent. The lessons from the COVID-19 pandemic underscore the importance of timely and effective health interventions to prevent another public health crisis.
